Gotorbe, C.; Segui, F.; Echavidre, W.; Durivault, J.; Blanchard, T.; Vial, V.; Pagnuzzi-Boncompagni, M.; Villeneuve, R.; Amblard, R.; Garnier, N.;
et al. Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis. Curr. Oncol. 2024, 31, 7390-7402.
https://doi.org/10.3390/curroncol31110545
AMA Style
Gotorbe C, Segui F, Echavidre W, Durivault J, Blanchard T, Vial V, Pagnuzzi-Boncompagni M, Villeneuve R, Amblard R, Garnier N,
et al. Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis. Current Oncology. 2024; 31(11):7390-7402.
https://doi.org/10.3390/curroncol31110545
Chicago/Turabian Style
Gotorbe, Célia, Fabien Segui, William Echavidre, Jérôme Durivault, Thays Blanchard, Valérie Vial, Marina Pagnuzzi-Boncompagni, Rémy Villeneuve, Régis Amblard, Nicolas Garnier,
and et al. 2024. "Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis" Current Oncology 31, no. 11: 7390-7402.
https://doi.org/10.3390/curroncol31110545
APA Style
Gotorbe, C., Segui, F., Echavidre, W., Durivault, J., Blanchard, T., Vial, V., Pagnuzzi-Boncompagni, M., Villeneuve, R., Amblard, R., Garnier, N., Ortholan, C., Serrano, B., Picco, V., Pouysségur, J., Vucetic, M., & Montemagno, C.
(2024). Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis. Current Oncology, 31(11), 7390-7402.
https://doi.org/10.3390/curroncol31110545
